These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 306851)

  • 1. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
    Sauer H; Wilmanns W
    Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 3. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
    Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
    Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate.
    Sauer H; Schalhorn A; Wilmanns W
    Eur J Cancer (1965); 1979 Oct; 15(10):1203-9. PubMed ID: 316389
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.
    Kiu MC; Liaw CC; Yang TS; Lai GM; Hsi SN; Lu CS
    Anticancer Drugs; 1994 Aug; 5(4):480-2. PubMed ID: 7949255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical control of high-dose methotrexate/Leucovorin rescue therapy.
    Wilmanns W; Sauer H; Schalhorn A
    Recent Results Cancer Res; 1980; 74():42-9. PubMed ID: 6969415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
    Jaffe N; Frei E; Traggis D; Bishop Y
    N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
    Jaffe N
    Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 1991 Sep; (270):4-7. PubMed ID: 1884556
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy in osteogenic sarcoma.
    Tichler TE; Am YB; Brenner HJ
    Prog Clin Biol Res; 1982; 99():49-75. PubMed ID: 6983080
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate revisited.
    Frei E
    Med Pediatr Oncol; 1976; 2(3):227-41. PubMed ID: 790144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.